Platinib launch pricing in 2024 revealed: How expensive is the new option for treating certain cancers?

Pralsetinib (Pralsetinib), this highly anticipated new targeted drug, brings new treatment hope to patients with certain types of cancer. As an innovative oral small molecule drug, it effectively inhibits the growth and spread of cancer cells by precisely binding to specific targets on tumor cells, demonstrating a unique therapeutic mechanism.

In clinical studies, Platinib has proven to have significant efficacy against certain cancers, not only significantly prolonging patients' survival but also improving their quality of life. Moreover, compared with traditional chemotherapy drugs, platinib has milder side effects and is more acceptable to patients.

However, the road to launch of Platinib in China is not smooth. At present, this drug has not been included in the national medical insurance list, so patients need to pay for it in full out-of-pocket. It is understood that the price of Platinib in the domestic market may be relatively high, which undoubtedly brings a heavy financial burden to many patient families. The price of Platinib per box with a specification of 100mg*120 capsules may be as high as RMB 60,000.

At the same time, the price of platinib in overseas markets is also high. Each box of the European and American versions of the original drug (specification100mg*60 pills) may be priced between RMB 40,000 and RMB 150,000. The specific price is affected by exchange rate fluctuations. Despite this, generic drugs of platinib have also appeared in overseas markets. Their drug ingredients are basically the same as the original drug, but the price is relatively low. For example, a box of 120 pills of generic drugs produced by a Lao pharmaceutical factory may cost only more than 4,000 yuan, which provides a more economical treatment option for some patients.

In general, platinib, as an innovative cancer treatment drug, brings new treatment hope to patients, but its high price also prohibits many patients. It is hoped that with the adjustment of medical insurance policies and intensified market competition in the future, the price of platinib will gradually decrease, benefiting more patients.